Biomerica Inc Revenue per Employee (BMRA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Biomerica Inc   (NASDAQ: BMRA)
 

Biomerica Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 16.96% in the fourth quarter 2026, year on year to cumulative value of $4 million, Biomerica Inc 's revenue per employee grew on a trailing twelve months basis to $ 89,060. The productivity of Biomerica Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 474 other companies have achieved higher revenue per employee. While Biomerica Inc 's total ranking has deteriorated compared to the previous quarter from 73 to 3377. Biomerica Inc has 50 employees.


What is Sales per Employee Ratio?







BMRA Revenue per Employee (May 31 2026)
IV. Quarter
(Feb 28 2026)
III. Quarter
(Nov 30 2025)
II. Quarter
(Aug 31 2025)
I. Quarter
(May 31 2025)
IV. Quarter
Y / Y Revenue Change 16.96 % -11.8 % -26.04 % -23.63 % -33.01 %
Sales per Employee (TTM) $ 89,060 86,520 89,160 97,680 106,220
BMRA's Total Ranking # 3377 # 73 # 78 # 58 # 2875
Seq. Revenue Change -11.25 % -18.43 % -12.32 % 84.25 % -33.07 %


Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 9
Healthcare Sector # 475
Overall Market # 3377

Revenue per Employee Statistics
High Average Low
$ 384,941 $ 135,837 $ 86,520
(Aug 31 2022)   (Feb 28 2026)



Financial Statements
Biomerica Inc 's Revenue MRQ $ 1 Millions Visit BMRA's Income Statement
Biomerica Inc 's Revenues TTM $ 4 Millions Visit BMRA's aggregate revenue growth
What are BMRA's Sales? Visit BMRA's Sales by Segment




Other Ratios
Biomerica Inc 's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BMRA's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BMRA's Competitors
Revenue per Employee for BMRA's Suppliers
Revenue per Employee for BMRA's Customers

You may also want to know
BMRA's Sales Growth Rates BMRA's Pe Price to earnings ratio BMRA's Receivables Turnover Ratio BMRA's Stock Quote
BMRA's Net Income Growth Rates BMRA's Ps Price to Sales ratio BMRA's Sales per Employee BMRA's Asset Turnover Ratio
BMRA's Net Margin BMRA's Pb Price to Book ratio BMRA's Financial Strength Ratios BMRA's Dividend Payout Ratio
Date modified: 2026-09-05T08:34:47+00:00




Companies with similar Revenue per Employee for 12 months ending May 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending May 31 2026Number of Employees May 31 2026
Autolus Therapeutics Plc  155,689.66 $ 117.390  Million 754 
Hyperion Defi inc   155,633.22 $ 1.401  Million
Marpai Inc  155,467.29 $ 16.635  Million 107 
National Vision Holdings Inc   154,774.39 $ 2,033.426  Million 13,138 
Medicinova Inc   153,413.50 $ 0.920  Million
Hyperfine Inc   151,225.49 $ 15.425  Million 102 
Plus Therapeutics Inc   150,107.14 $ 4.203  Million 28 
Encompass Health Corporation  147,764.29 $ 6,206.100  Million 42,000 
Lifestance Health Group Inc   144,588.45 $ 1,584.834  Million 10,961 
Lenz Therapeutics Inc   141,282.89 $ 21.475  Million 152 
Zymeworks Inc   140,632.58 $ 37.127  Million 264 
Healthlynked Corp  137,204.00 $ 1.372  Million 10 
Alector Inc   134,592.23 $ 13.863  Million 103 
Abeona Therapeutics Inc   133,154.87 $ 30.093  Million 226 
Ufp Technologies Inc   130,425.51 $ 632.042  Million 4,846 
Foxo Technologies Inc   129,405.95 $ 24.846  Million 192 
Capsovision Inc   129,333.33 $ 12.804  Million 99 
Dariohealth Corp   128,460.61 $ 21.196  Million 165 
Beyond Air Inc   123,648.15 $ 6.677  Million 54 
Ensign Group Inc  119,276.26 $ 5,486.708  Million 46,000 
Profound Medical Corp   117,814.81 $ 19.086  Million 162 
Abcellera Biologics Inc   117,747.33 $ 66.174  Million 562 
Nrx Pharmaceuticals Inc   117,034.48 $ 3.394  Million 29 
Pacs Group Inc   116,974.78 $ 5,551.038  Million 47,455 
Renovorx Inc   116,235.29 $ 1.976  Million 17 
Nurix Therapeutics Inc   115,981.07 $ 36.766  Million 317 
Metagenomi Therapeutics Inc   113,957.98 $ 13.561  Million 119 
The Pennant Group Inc   113,578.35 $ 1,101.710  Million 9,700 
Amarin Corp Plcuk  113,018.18 $ 186.480  Million 1,650 
Catheter Precision Inc   112,647.06 $ 1.915  Million 17 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.